Wave Life Sciences at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Wave Life Sciences brings 7 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 428. Its program centers on body composition as a measure of treatment success and on the INHBE-activin E pathway as an obesity target. Its most concrete work shows that silencing Inhbe with a GalNAc-SpiNA siRNA drives tissue remodeling and a healthier metabolic profile.

OrganizationObesityWeek 2026 Attendance
Wave Life Sciences
Cambridge, MA
◇Bronze Sponsor
BiotechBronze Sponsor
RNA medicines company whose pipeline includes WVE-007 for obesity, plus programs in alpha-1 antitrypsin deficiency and PNPLA3-linked liver disease.
Booth
Exhibiting at Booth 428
Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm
Talk
Sat Nov 14
11:45am–1:15pm
Rethinking Success in the Treatment of Overweight and Obesity Through Body Composition: What Are We Made of?
Asks whether body composition, not weight loss alone, should measure obesity treatment success, and reviews activin E biology and small interfering RNA drugs.
Riverview Ballroom A
with knownwell
Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development
Talk
Sat Nov 14
11:55am–12:10pm
Changing the Treatment Paradigm in Overweight and Obesity Management
Riverview Ballroom A
with knownwell, Brigham and Women's Hospital
Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development
Talk
Sat Nov 14
12:10pm–12:35pm
Beyond The Scale: The Clinical Relevance of Body Composition, Body Fat Distribution and Lean Mass
Riverview Ballroom A
with knownwell, Brigham and Women's Hospital
Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development
Talk
Sat Nov 14
12:35pm–1:00pm
From Genetic Evidence to Therapeutic Hypothesis: the INHBE-Activin E Pathway as a Target for Obesity Management
Riverview Ballroom A
Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development
Talk
Sat Nov 14
1:10pm–1:15pm
Rethinking Success: Where Should Obesity Treatment Go?
Riverview Ballroom A
with knownwell
Interventional and clinical studiesPopulation health and epidemiologyClinical obesity care and professional practiceMetabolism and integrative physiologyObesity pharmacotherapy and drug development
Poster
Sun Nov 15
2:30pm–3:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Wave Life Sciences

Tell us what you sell and we’ll find the people at Wave Life Sciences most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction